One shortcoming in determining axial disease activity is the BASDAI itself. And yet, this study by Dr. @AlexisOgdie shows that the BASDAI scores were similar in those w and w/o axial disease in PsA. Dr. Mease. And yet not all drugs work equally in PsA/axSpA. #RNL2022 @RheumNow https://t.co/h1PYfNgEV3